Fridays Tirzepatide: Dual-Agonist Sourcing, Pricing, and Pathways

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

This is independent editorial coverage. PlexusDx has no commercial relationship with Fridays or its parent company, and no affiliate links or compensation are involved anywhere in this piece.

Full head-to-head: PlexusDx vs Fridays →

Searches for "Fridays tirzepatide" want the compound-specific answer, so that is the focus here: how Fridays handles tirzepatide, why the molecule behaves differently from single-agonist GLP-1 drugs, and what a prescription alone cannot see. Presented as balanced context rather than a buying steer. As of April 2026.

Fridays and the tirzepatide pathway

Fridays (Fridays Health) pairs telehealth with a compounded-pharmacy supply chain. For tirzepatide, that typically involves a virtual clinical evaluation, a licensed provider's review, and — when eligibility is met — a prescription routed either to a retail pharmacy for an FDA-approved brand or to a 503A compounding pharmacy for compounded tirzepatide, followed by ongoing follow-up. Current specifics live on Fridays's official website.

Why tirzepatide is a dual agonist

Tirzepatide is not a plain GLP-1 receptor agonist. It is a GIP/GLP-1 dual agonist, engaging two incretin receptors rather than one — which is why it sits in its own class relative to semaglutide, liraglutide, and dulaglutide. Its clinical record includes the SURMOUNT program for weight management (NEJM, 2022) and SURMOUNT-OSA for obstructive sleep apnea (NEJM, 2024). Populations and endpoints vary by trial, and outcomes vary individually.

Dual agonism in practice

The second receptor is the reason tirzepatide is often discussed separately from semaglutide in dosing, titration, and tolerability conversations. Those clinical judgments belong with a prescribing clinician, not a web page, and Fridays' own materials describe how its providers manage them.

Branded tirzepatide vs a compounded formulation

As with semaglutide, "tirzepatide" spans two supply routes. FDA-approved branded tirzepatide is manufactured and dispensed through retail pharmacies; compounded tirzepatide is prepared by a 503A pharmacy against an individual script and is not an FDA-approved product. The two are not interchangeable, and which one a Fridays plan uses is stated on the brand's pages.

What Fridays charges for tirzepatide

Fridays lists its own pricing. As of its pricing page (joinfridays.com/pricing, verified 2026-07-20), Fridays advertises compounded tirzepatide at $359/mo as an ongoing month-to-month rate, with $0 membership, free shipping, and included coaching and dietitian support; a paid-annually plan works out to roughly $240/mo. Fridays' rates moved materially within a single day. For context, PlexusDx's month-to-month rate runs roughly $60–$70/mo below Fridays' advertised month-to-month, and Fridays also sells prepaid 3- and 6-month bundles. Confirm live figures at Fridays's official website before committing.

The upstream biology no tirzepatide script measures

A tirzepatide prescription acts on metabolic machinery it never characterizes. Variants in GLP1R (the GLP-1 receptor gene), FTO (the fat-mass and obesity-associated gene), MC4R (a satiety and energy-balance receptor), and TCF7L2 (linked to glucose homeostasis and incretin signaling) sketch the baseline terrain a dual agonist engages. They are pathway-level markers: they do not forecast your tirzepatide response, but they describe the biology behind the prescription.

The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, MC4R, and TCF7L2 variants that shape appetite-regulation and energy-balance biology. Knowing that profile before you begin is the test before you invest approach: turning guesswork into an informed conversation with your provider.

PlexusDx tirzepatide protocols in context

PlexusDx offers tirzepatide and semaglutide through its Weight Management Protocols — including Tirzepatide Injection and Tirzepatide Oral, plus Semaglutide Injection and Semaglutide Oral. The upstream genetic context is what separates the approach from a script issued in isolation.

Not affiliated: PlexusDx is not affiliated with Fridays and has no commercial relationship with the companies reviewed in this article.

Related reading on PlexusDx: GLP 1 vs Mounjaro, How To Buy Mounjaro, Injection Mounjaro, Microdose Mounjaro.

Disclaimer: This article is educational. PlexusDx is not affiliated with Fridays and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Frequently Asked Questions

Why is tirzepatide priced higher than semaglutide at Fridays?

Fridays advertises compounded tirzepatide at $359/mo month-to-month versus $249/mo for semaglutide (verified 2026-07-20). Different compounds carry different supply and formulation costs. Prepaid annual plans lower both per-month equivalents. Rates moved within a single day, so confirm current figures on the brand's own site.

Is Fridays tirzepatide compounded or branded?

Fridays uses a telehealth-plus-compounded-pharmacy model, so tirzepatide may arrive as an FDA-approved brand from a retail pharmacy or as compounded tirzepatide from a 503A pharmacy. The route depends on the plan and eligibility. The brand's own pages state which applies before you buy.

Does a genetic test predict how I will respond to tirzepatide?

No. The Precision Peptide Genetic Test does not predict response to tirzepatide or any dual agonist. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline incretin and energy-balance biology — context that applies whichever program prescribes the compound.

How does PlexusDx tirzepatide compare to Fridays?

PlexusDx offers tirzepatide through its Weight Management Protocols with the Precision Peptide Genetic Test for genetic context. Its month-to-month rate runs roughly $60–$70/mo below Fridays' advertised month-to-month, and Fridays also sells prepaid multi-month bundles. The differentiator is pathway-level insight.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.